When hidden risks like insulin resistance and liver stress are identified early, tools like GLP-1s can help stabilize your system and protect your heart health for the long haul
Response to letter regarding article, Heart failure, saxagliptin and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial
The novel synergistically acting glucagon-like peptide-1 (GLP-1) receptor agonist combined with the amylin agonist, CagriSema, shows promising results in both glucose regulation and weight management
Holistic support includes: Ensuring nutrient-dense meals
These visits allow your doctor to review blood pressure trends, assess weight loss progress, and make informed decisions about whether to maintain, reduce, or adjust any of your antihypertensive medications